(1999). Germline deletion of the nucleoside triphosphate pyrophosphohydrolase (NTPPPH) plasma cell membrane glycoprotein-1 (PC-1) produces abnormal calcification of periarticular tissues.
(2009). Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice.
(2010). Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick.
(2008). Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study.
(2006). Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.
Lowik CW (2005) Bone morphogenic proteins and their antagonists: the sclerostin paradigm.
(2004). Matrix metalloproteinases (MMPs) safeguard osteoblasts from apoptosis during transdifferentiation into osteocytes: MT1-MMP maintains osteocyte viability.
(2008). Matrix mineralization as a trigger for osteocyte maturation.
(2003). Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo.
(1999). Medial localization of mineralization-regulating proteins in association with Mo ¨nckeberg’s sclerosis: evidence for smooth muscle cell-mediated vascular calcification.
(1999). Microtubules are potential regulators of growth-plate chondrocyte differentiation and hypertrophy.
(2005). Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals.
(1998). Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine.
(2003). Mutations in Enpp1 are associated with ‘idiopathic’ infantile arterial calcification.